智通财经APP讯，华纳药厂(688799.SH)发布公告，近日，公司全资子公司湖南华纳大药厂手性药物有限公司(简称“手性药物”)收到国家药品监督管理局签发的艾拉莫德《化学原料药上市申请批准通知书》(通知书编号：2026YS00837)，并在国家药品监督管理局药品审评中心(CDE)“原辅包登记信息”平台公示。
艾拉莫德是艾拉莫德片的原料药。艾拉莫德片主要用于治疗活动性类风湿关节炎。
智通财经APP讯，华纳药厂(688799.SH)发布公告，近日，公司全资子公司湖南华纳大药厂手性药物有限公司(简称“手性药物”)收到国家药品监督管理局签发的艾拉莫德《化学原料药上市申请批准通知书》(通知书编号：2026YS00837)，并在国家药品监督管理局药品审评中心(CDE)“原辅包登记信息”平台公示。
艾拉莫德是艾拉莫德片的原料药。艾拉莫德片主要用于治疗活动性类风湿关节炎。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.